Regler^®

Dexlansoprazole

Description
Regler® (Dexlansoprazole) delayed-release capsule is a Proton Pump Inhibitor (PPI), that inhibits gastric acid secretion. Regler® (Dexlansoprazole) is the R-enantiomer of lansoprazole (A racemic mixture of the R- and S-enantiomers). Regler® (Dexlansoprazole) is supplied as a Dual Delayed Release (DDR) formulation in a capsule for oral administration. Regler® (Dexlansoprazole) capsule contains a mixture of two types of enteric coated granules with different pH-dependent dissolution profiles.

Indications
• Healing of Erosive Esophagitis: Regler® (Dexlansoprazole) is indicated for healing of all grades of Erosive Esophagitis (EE) for up to 8 weeks • Maintenance of Healed Erosive Esophagitis: Regler® (Dexlansoprazole) is indicated to maintain healing of EE and relief of heartburn for up to 6 months • Symptomatic Non-Erosive Gastroesophageal Reflux Disease: Regler® (Dexlansoprazole) is indicated for the treatment of heartburn associated with symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD) for 4 weeks.

Supply
Regler® 30: Each box contains 5x10's capsules in Alu-Alu blister pack.
Regler® 60: Each box contains 5x6's capsules in Alu-Alu blister pack.